DE602005010276D1 - Neues peptid und pharmazeutische zusammensetzung, die dieses peptid enthält - Google Patents
Neues peptid und pharmazeutische zusammensetzung, die dieses peptid enthältInfo
- Publication number
- DE602005010276D1 DE602005010276D1 DE602005010276T DE602005010276T DE602005010276D1 DE 602005010276 D1 DE602005010276 D1 DE 602005010276D1 DE 602005010276 T DE602005010276 T DE 602005010276T DE 602005010276 T DE602005010276 T DE 602005010276T DE 602005010276 D1 DE602005010276 D1 DE 602005010276D1
- Authority
- DE
- Germany
- Prior art keywords
- peptide
- pharmaceutical composition
- composition containing
- cell
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000004075 alteration Effects 0.000 abstract 2
- 210000002615 epidermis Anatomy 0.000 abstract 1
- 108010028309 kalinin Proteins 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000003014 reinforcing effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0408383A FR2873698B1 (fr) | 2004-07-29 | 2004-07-29 | Nouveau peptide et composition pharmaceutique le contenant |
PCT/FR2005/001999 WO2006018551A1 (fr) | 2004-07-29 | 2005-07-29 | Nouveau peptide et composition pharmaceutique le contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005010276D1 true DE602005010276D1 (de) | 2008-11-20 |
Family
ID=34950308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005010276T Active DE602005010276D1 (de) | 2004-07-29 | 2005-07-29 | Neues peptid und pharmazeutische zusammensetzung, die dieses peptid enthält |
Country Status (8)
Country | Link |
---|---|
US (1) | US7645740B2 (de) |
EP (1) | EP1784423B1 (de) |
AT (1) | ATE410448T1 (de) |
CA (1) | CA2575387C (de) |
DE (1) | DE602005010276D1 (de) |
ES (1) | ES2317308T3 (de) |
FR (1) | FR2873698B1 (de) |
WO (1) | WO2006018551A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2943062B1 (fr) | 2009-03-13 | 2011-04-08 | Symatese | Nouveau peptide promoteur de l'adhesion et de la migration cellulaire |
KR102065171B1 (ko) * | 2019-02-20 | 2020-01-13 | (주)케어젠 | 대기오염물질에 의한 피부 손상 방지 및 항노화용 펩타이드와 이의 용도 |
KR102474470B1 (ko) * | 2020-11-25 | 2022-12-07 | (주)케어젠 | 미세먼지에 의한 세포 손상 방지 활성을 갖는 펩타이드 및 이의 용도 |
KR102539445B1 (ko) * | 2020-11-25 | 2023-06-05 | (주)케어젠 | 미세먼지에 의한 세포 손상 방지 활성을 갖는 펩타이드 및 이의 용도 |
FR3127219A1 (fr) | 2021-09-20 | 2023-03-24 | Laboratoires D'anjou | Nouveaux peptides et compositions pharmaceutiques et cosmetiques les contenants |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294356B1 (en) * | 1998-01-16 | 2001-09-25 | Northwestern University | Methods and materials for making and using laminin-5 |
AU4675300A (en) * | 1999-04-30 | 2000-11-17 | Biostatum, Inc. | Recombinant laminin 5 |
JP4377522B2 (ja) * | 2000-05-09 | 2009-12-02 | 株式会社ヤクルト本社 | 安定な酸性乳飲料、その製造方法およびこれに使用する酸性乳飲料用添加剤 |
-
2004
- 2004-07-29 FR FR0408383A patent/FR2873698B1/fr not_active Expired - Fee Related
-
2005
- 2005-07-29 EP EP05793330A patent/EP1784423B1/de active Active
- 2005-07-29 US US11/572,774 patent/US7645740B2/en active Active
- 2005-07-29 ES ES05793330T patent/ES2317308T3/es active Active
- 2005-07-29 CA CA2575387A patent/CA2575387C/fr active Active
- 2005-07-29 AT AT05793330T patent/ATE410448T1/de not_active IP Right Cessation
- 2005-07-29 DE DE602005010276T patent/DE602005010276D1/de active Active
- 2005-07-29 WO PCT/FR2005/001999 patent/WO2006018551A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
ATE410448T1 (de) | 2008-10-15 |
ES2317308T3 (es) | 2009-04-16 |
WO2006018551A1 (fr) | 2006-02-23 |
EP1784423A1 (de) | 2007-05-16 |
FR2873698A1 (fr) | 2006-02-03 |
CA2575387C (fr) | 2014-09-02 |
US7645740B2 (en) | 2010-01-12 |
FR2873698B1 (fr) | 2006-10-20 |
EP1784423B1 (de) | 2008-10-08 |
WO2006018551A8 (fr) | 2006-04-27 |
US20080064641A1 (en) | 2008-03-13 |
CA2575387A1 (fr) | 2006-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0214029A (pt) | Métodos e composições para o uso de células estromais para suportar células tronco embriÈnicas e adultas | |
BR0308429A (pt) | Aroilpiridinonas monocìclicas como agentes antiinflamatórios | |
NZ592911A (en) | Leukolectins and uses thereof | |
UY27127A1 (es) | Derivados de la urea como antagonistas de integrin alfa-4 | |
NL300808I2 (nl) | susoctocog alfa | |
HK1109070A1 (en) | Treatment articles capable of conforming to an underlying shape | |
UY28258A1 (es) | Tratamiento terapeutico | |
TR201903008T4 (tr) | Kollajen-aracılı hastalıkları tedavi etmek için uygun bileşimler. | |
EE05212B1 (et) | Polpeptiidi kasutamine farmatseutilise kompositsiooni valmistamiseks, mis on m?eldud kasvajaraku raviks, mis ekspresseerib APRIL-i | |
ITMI20041550A1 (it) | Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide | |
RS54215B1 (en) | COMPOSITIONS AND PROCEDURES FOR DIAGNOSIS AND TREATMENT OF CANCER | |
MXPA06003474A (es) | Agonistas de receptores de melanocortina. | |
ATE410448T1 (de) | Neues peptid und pharmazeutische zusammensetzung, die dieses peptid enthält | |
DE602006012115D1 (de) | Behandlung von amyotrophischer lateralsklerose mit pyrimethamin und analoga | |
DE60125563D1 (de) | Verfahren zur verwendung eines humanen il-17 verwandten polypeptids zur behandlung von krankheiten | |
GB0620255D0 (en) | Antibody and uses thereof | |
AR061352A1 (es) | El uso de timosina alfa 1 para preparar un medicamento destinado al tratamiento del melanoma maligno de estadio iv | |
ATE526056T1 (de) | Igf-2 peptid zur verwendung in einer tolerogenen behandlung für typ i diabetes | |
CY1108048T1 (el) | Συνθεση σπογγοσινης | |
ECSP045210A (es) | 2' - halo - 3' , 5' - dialcoxi - fen - 1' - il - imino - 2 -imidazolidinas y su uso como un fármaco | |
HUP0102046A2 (hu) | CD137 alkalmazása perifériás monociták proliferációjának serkentésére | |
NO20052525D0 (no) | Spleisevariant av humant hypofyseveksthormon | |
DE60132466D1 (de) | Verfahren zur kultivierung von menschlichen lungenmastzellen und deren anwendungen | |
DK1748785T3 (da) | Peptider til modulering af bruskhomeostase | |
DE602004019141D1 (de) | Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonin (ivtntt) enthaltende biologisch wirksame peptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |